S

Researcher Profile

Sophie Cousin

4

Publications

628

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Nature Medicine Feb 13, 2024

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Benjamin Besse · Elvire Pons-Tostivint · Keunchil Park · Sylvia Hartl +34 more

10.1038/s41591-024-02808-y 98 citations

Open Access Journal Article Cell Reports Medicine Dec 01, 2024

Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response

Jean-Philippe Guegan · Florent Peyraud · Berengère Dadone-Montaudie · Diego Teyssonneau +19 more

10.1016/j.xcrm.2024.101831 28 citations

Journal Article Nature Cancer Aug 12, 2021

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

Lucile Vanhersecke · Maxime Brunet · Jean-Philippe Guegan · Christophe Rey +29 more

10.1038/s43018-021-00232-6 494 citations

Journal Article Journal of Clinical Oncology May 20, 2021

Regomune: A phase II study of regorafenib + avelumab in solid tumors—Results of the biliary tract cancer (BTC) cohort.

Sophie Cousin · Carine A. Bellera · Jean Philippe Guégan · Thibault Mazard +12 more

10.1200/jco.2021.39.15_suppl.4096 8 citations

Publication Timeline

2024

2

2021

2

Frequent Co-Authors

Antoine Italiano

Lucile Vanhersecke

Jean-Philippe Guegan

Mathilde Cabart

Isabelle Soubeyran

Guilhem Roubaud

Sylvestre Le Moulec